Sanofi Diluted Earnings Loss Per Share From Continuing Operations
Sanofi (SNY) reported Diluted Earnings Loss Per Share From Continuing Operations of 4.03 EUR/shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations · last filed 2026-02-17
| Period end | Diluted Earnings Loss Per Share From Continuing Operations 6 month | Diluted Earnings Loss Per Share From Continuing Operations 12 month | Diluted Earnings Loss Per Share From Continuing Operations 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 4.03 EUR/shares 20-F · filed 2026-02-17 | ||
| 2025-06-30 | 2.39 EUR/shares 6-K · filed 2025-10-27 | ||
| 2024-12-31 | 4.39 EUR/shares 20-F · filed 2026-02-17 | ||
| 2024-06-30 | 1.63 EUR/shares 6-K · filed 2025-10-27 | ||
| 2023-12-31 | 4.05 EUR/shares 20-F · filed 2026-02-17 | ||
| 2022-12-31 | 6.35 EUR/shares 20-F · filed 2025-02-13 | ||
| 2021-12-31 | 4.95 EUR/shares 20-F · filed 2022-02-23 | ||
| 2020-12-31 | 9.76 EUR/shares 20-F · filed 2022-02-23 | 9.77 EUR/shares 20-F · filed 2021-03-04 | |
| 2020-06-30 | 7.38 EUR/shares 6-K · filed 2020-07-29 | ||
| 2019-12-31 | 2.27 EUR/shares 20-F · filed 2022-02-23 | 2.31 EUR/shares 20-F · filed 2020-03-05 | |
| 2019-06-30 | 0.84 EUR/shares 6-K · filed 2020-07-29 | ||
| 2018-12-31 | 3.44 EUR/shares 20-F · filed 2021-03-04 | ||
| 2017-12-31 | 2.98 EUR/shares 20-F · filed 2020-03-05 | 2.99 EUR/shares 20-F/A · filed 2018-03-16 | |
| 2016-12-31 | 3.39 EUR/shares 20-F · filed 2019-03-08 | ||
| 2015-12-31 | 3.34 EUR/shares 20-F/A · filed 2018-03-16 |